Minimal residual disease in high-risk neuroblastoma shows a dynamic and disease burden-dependent correlation between bone marrow and peripheral blood-Reference-Cited by-同舟云学术

Minimal residual disease in high-risk neuroblastoma shows a dynamic and disease burden-dependent correlation between bone marrow and peripheral blood

Published:2021-08 Issue:8 Volume:14 Page:101019
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Lin Kyaw San^ORCID,Uemura Suguru,Thwin Khin Kyae Mon,Nakatani Naoko,Ishida Toshiaki^ORCID,Yamamoto Nobuyuki,Tamura Akihiro^ORCID,Saito Atsuro,Mori Takeshi,Hasegawa Daiichiro,Kosaka Yoshiyuki,Nino Nanako,Nagano China,Takafuji Satoru,Iijima Kazumoto,Nishimura Noriyuki^ORCID

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference45 articles.

1. Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla;Furlan;Science,2017

2. Origin and initiation mechanisms of neuroblastoma;Tsubota;Cell Tissue Res,2018

3. Hijacking of embryonic programs by neural crest-derived neuroblastoma: from physiological migration to metastatic dissemination;Delloye-Bourgeois;Front Mol Neurosci,2019

4. Neuroblastoma: biological insights into a clinical enigma;Brodeur;Nat Rev Cancer,2003

5. Neuroblastoma;Maris;Lancet,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on liquid biopsies in neuroblastoma for treatment response, relapse and recurrence assessment;Cancer Genetics;2024-11

2. Salvage chemotherapy regimens with arsenic trioxide for relapsed or refractory neuroblastoma: a promising approach;BMC Cancer;2024-09-12

3. Distinct Expression Profiles of Neuroblastoma-Associated mRNAs in Peripheral Blood and Bone Marrow of Non-High-Risk and High-Risk Neuroblastoma Patients;Biology;2024-05-15

4. Higher levels of minimal residual disease in peripheral blood than bone marrow before 1st and 2nd relapse/regrowth in a patient with high‑risk neuroblastoma: A case report;Oncology Letters;2023-07-14

5. Biological Insight and Recent Advancement in the Treatment of Neuroblastoma;International Journal of Molecular Sciences;2023-05-09